Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Episource is a leading provider of risk adjustment and quality solutions for health plans and medical groups. The company offers a comprehensive suite of services and software designed to simplify the complexities of healthcare data management, including medical coding, clinical documentation improvement, and health risk assessments. By leveraging advanced analytics and a global workforce, Episource helps healthcare organizations optimize their financial performance and improve patient care quality. Following its acquisition by Optum in 2023, Episource continues to operate as a key component of Optum's data and analytics ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Episource.